Clinical Ophthalmology (Auckland, N.Z.) · 5 authors, 4 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
A prospective, single-arm study of 52 eyes with mild open-angle glaucoma bilaterally implanted with a non-diffractive EDOF IOL found favorable uncorrected distance and intermediate visual acuity and favorable contrast sensitivity at 4 months postoperatively.
Seventy-seven percent of patients also received a trabecular microbypass stent at the time of surgery. Outcomes were collected at a 4-month postoperative visit. The mean binocular UDVA was 0.03 ± 0.12 LogMAR with 65% achieving 20/20 or better, and mean binocular UIVA was 0.17 ± 0.12 LogMAR with 77% achieving 20/32 or better. Eighty-five percent of subjects reported they would choose the same lens again. Limitations include the absence of a control group, a relatively small sample size, restriction to mild glaucoma stages, lack of pupillometry, and contrast sensitivity measured only at a single spatial frequency. This is the first study evaluating the Vivity EDOF IOL specifically in eyes with glaucoma.
